Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
The candidate microbicide CADA, an entry inhibitor that specifically targets the cellular CD4 receptor, prevents HIV and SIV infection of human and simian cells
Kurt Vermeire, Thomas W. Bell, S. Anugu, N.H. Duffy, Roger Le Grand, De Clercq Erik, Dominique Schols (2006). The candidate microbicide CADA, an entry inhibitor that specifically targets the cellular CD4 receptor, prevents HIV and SIV infection of human and simian cells. , 70(1)
Article80 days agoCADA, a novel antiretroviral drug with specific CD4 down-modulating activity
Kurt Vermeire, Sigrid Hatse, De Clercq Erik, K Dey, M Samala, A Sodoma, Thomas W. Bell, Dominique Schols (2002). CADA, a novel antiretroviral drug with specific CD4 down-modulating activity.
Article80 days agoThe anti-HIV and anti-HHV-7 potency of CADA analogs is strictly correlated with their ability to down-modulate the CD4 receptor
Kurt Vermeire, Thomas W. Bell, De Clercq Erik, Dominique Schols (2002). The anti-HIV and anti-HHV-7 potency of CADA analogs is strictly correlated with their ability to down-modulate the CD4 receptor.
Article80 days agoCADA, a specific CD4 down-modulating compound with potent anti-HIV activity
Dominique Schols, Kurt Vermeire, Sigrid Hatse, K Dey, M Samala, A Sodoma, De Clercq Erik, Thomas W. Bell (2002). CADA, a specific CD4 down-modulating compound with potent anti-HIV activity.
Article80 days agoCADA compounds: inhibitors of HIV and HHV-7 replication via down-modulation of CD4 receptor expression
Thomas W. Bell, K Dey, Qi Jin, M Samala, Emily Scarbrough, A Sodoma, Kurt Vermeire, De Clercq Erik, Dominique Schols (2001). CADA compounds: inhibitors of HIV and HHV-7 replication via down-modulation of CD4 receptor expression.
Article80 days ago